This research report titled ‘Global Cardiac Pacemakers Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
In 2016, the Americas dominated the global cardiac pacemakers market, accounting for the largest share, followed by EMEA and APAC. However, APAC is expected to grow at the fastest growth rate as the regional manufacturers in APAC are offering low-cost products. This is encouraging the global vendors like Boston Scientific, BIOTRONIK, Medtronic, and Abbott's subsidiary St. Jude Medical to lower their products prices in this region. Also, the demand for these products are more than supply with high unmet medical needs in most of developing countries such as India, Bangladesh, Sri Lanka, Malaysia, China, Thailand, Singapore, and South Korea.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio’s healthcare and life sciences research analysts categorize the global cardiac pacemakers market into the following segments by technology. They are:
- Single-chamber cardiac pacemakers
- Dual-chamber cardiac pacemakers
- Bi-ventricular cardiac pacemakers
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Single-chamber cardiac pacemakers
Pacemakers are used to treat cardiac-related medical conditions powered by a battery. The device sends an electrical signal to the heart to make it pump at an adequate pace. Pacemakers are placed beneath the individual's collarbone typically in the right ventricle or atrium connected to the heart with the help of leads or wires. When one lead or wire is placed within the lower chamber of the heart, it is known as the single-chamber pacemaker.
According to Neha Noopur, a lead cardiovascular devices research analyst from Technavio, “The single-chamber pacemakers are commonly used in the management of bradycardias and chronic atrial fibrillation. It is a relatively simple procedure as the only single lead is implanted with a smaller generator. The time required to perform this procedure is short with fewer complications.”
Dual-chamber cardiac pacemakers
The dual-chamber technology in pacemakers maintains the usual synchrony of atrial and ventricular contraction of the sinus node. It has one lead placed in the atrium and another in the ventricle of the heart, which reduces the risk of atrial fibrillation, stroke, and death due to heart diseases.
“The dual-chamber pacemakers are considered in individuals with sinus node dysfunction or atrioventricular block after joint consensus statement issued by the Heart Rhythm Society and American College of Cardiology Foundation. Several manufacturers develop dual-chamber pacemakers. For instance, Abbott's subsidiary St. Jude Medical develops dual-chamber pacemaker ASSURITY to manage cardiac rhythm. The introduction of dual-chamber pacemakers by various manufacturers with advanced technological features will boost the global cardiac pacemakers market in the coming years,” adds Neha.
Bi-ventricular cardiac pacemakers
A bi-ventricular cardiac pacemaker is commonly known as cardiac resynchronization therapy (CRT). It is used to treat delay in heart ventricle contractions in individuals with advanced heart failure. It is an electronic battery-powered device, which is surgically implanted under the skin. Such device has 2-3 leads or wires attached to the heart to balance the heartbeat. The leads are placed through a vein in the right atrium, right ventricle, and coronary sinus vein to pace left ventricle.
The bi-ventricular technology is relatively a new approach to treat arrhythmia, and it significantly improves the survival rate among individuals with heart failure symptoms. The device is recommended to be safe to use with minimal risk, proved to improve ejection fraction (percentage of blood that leaves heart at the time of contraction), and showed to improve the quality of life.
The top vendors highlighted by Technavio’s research analysts in this report are:
- Boston Scientific
Browse Related Reports:
- Global Cardiovascular Catheters Market 2017-2021
- Global Hemodialysis Catheters Market 2017-2021
- Global Bare Metal Stents Market 2017-2021
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.